Prognostic implication of 1-year decline in diffusing capacity in newly diagnosed idiopathic pulmonary fibrosis

Abstract The progression of idiopathic pulmonary fibrosis (IPF) is assessed through serial monitoring of forced vital capacity (FVC). Currently, data regarding the clinical significance of longitudinal changes in diffusing capacity for carbon monoxide (DLCO) is lacking. We investigated the prognosti...

Full description

Bibliographic Details
Main Authors: Hyeonsu Lee, So Yeon Kim, Young Sik Park, Sun Mi Choi, Jong Hyuk Lee, Jimyung Park
Format: Article
Language:English
Published: Nature Portfolio 2024-04-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-59649-5
_version_ 1797199488043974656
author Hyeonsu Lee
So Yeon Kim
Young Sik Park
Sun Mi Choi
Jong Hyuk Lee
Jimyung Park
author_facet Hyeonsu Lee
So Yeon Kim
Young Sik Park
Sun Mi Choi
Jong Hyuk Lee
Jimyung Park
author_sort Hyeonsu Lee
collection DOAJ
description Abstract The progression of idiopathic pulmonary fibrosis (IPF) is assessed through serial monitoring of forced vital capacity (FVC). Currently, data regarding the clinical significance of longitudinal changes in diffusing capacity for carbon monoxide (DLCO) is lacking. We investigated the prognostic implications of a 1-year decline in DLCO in 319 patients newly diagnosed with IPF at a tertiary hospital between January 2010 and December 2020. Changes in FVC and DLCO over the first year after the initial diagnosis were reviewed; a decline in FVC ≥ 5% and DLCO ≥ 10% predicted were considered significant changes. During the first year after diagnosis, a significant decline in FVC and DLCO was observed in 101 (31.7%) and 64 (20.1%) patients, respectively. Multivariable analysis showed that a 1-year decline in FVC ≥ 5% predicted (aHR 2.74, 95% CI 1.88–4.00) and 1-year decline in DLCO ≥ 10% predicted (aHR 2.31, 95% CI 1.47–3.62) were independently associated with a higher risk of subsequent mortality. The prognostic impact of a decline in DLCO remained significant regardless of changes in FVC, presence of emphysema, or radiographic indications of pulmonary hypertension. Therefore, serial monitoring of DLCO should be recommended because it may offer additional prognostic information compared with monitoring of FVC alone.
first_indexed 2024-04-24T07:16:33Z
format Article
id doaj.art-a99ecdc533fe40abbf50fff01181f1db
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-24T07:16:33Z
publishDate 2024-04-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-a99ecdc533fe40abbf50fff01181f1db2024-04-21T11:15:47ZengNature PortfolioScientific Reports2045-23222024-04-011411910.1038/s41598-024-59649-5Prognostic implication of 1-year decline in diffusing capacity in newly diagnosed idiopathic pulmonary fibrosisHyeonsu Lee0So Yeon Kim1Young Sik Park2Sun Mi Choi3Jong Hyuk Lee4Jimyung Park5Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University HospitalDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University HospitalDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University HospitalDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University HospitalDepartment of Radiology, Seoul National University HospitalDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University HospitalAbstract The progression of idiopathic pulmonary fibrosis (IPF) is assessed through serial monitoring of forced vital capacity (FVC). Currently, data regarding the clinical significance of longitudinal changes in diffusing capacity for carbon monoxide (DLCO) is lacking. We investigated the prognostic implications of a 1-year decline in DLCO in 319 patients newly diagnosed with IPF at a tertiary hospital between January 2010 and December 2020. Changes in FVC and DLCO over the first year after the initial diagnosis were reviewed; a decline in FVC ≥ 5% and DLCO ≥ 10% predicted were considered significant changes. During the first year after diagnosis, a significant decline in FVC and DLCO was observed in 101 (31.7%) and 64 (20.1%) patients, respectively. Multivariable analysis showed that a 1-year decline in FVC ≥ 5% predicted (aHR 2.74, 95% CI 1.88–4.00) and 1-year decline in DLCO ≥ 10% predicted (aHR 2.31, 95% CI 1.47–3.62) were independently associated with a higher risk of subsequent mortality. The prognostic impact of a decline in DLCO remained significant regardless of changes in FVC, presence of emphysema, or radiographic indications of pulmonary hypertension. Therefore, serial monitoring of DLCO should be recommended because it may offer additional prognostic information compared with monitoring of FVC alone.https://doi.org/10.1038/s41598-024-59649-5Idiopathic pulmonary fibrosisPulmonary diffusing capacityVital capacityDisease progressionRespiratory function test
spellingShingle Hyeonsu Lee
So Yeon Kim
Young Sik Park
Sun Mi Choi
Jong Hyuk Lee
Jimyung Park
Prognostic implication of 1-year decline in diffusing capacity in newly diagnosed idiopathic pulmonary fibrosis
Scientific Reports
Idiopathic pulmonary fibrosis
Pulmonary diffusing capacity
Vital capacity
Disease progression
Respiratory function test
title Prognostic implication of 1-year decline in diffusing capacity in newly diagnosed idiopathic pulmonary fibrosis
title_full Prognostic implication of 1-year decline in diffusing capacity in newly diagnosed idiopathic pulmonary fibrosis
title_fullStr Prognostic implication of 1-year decline in diffusing capacity in newly diagnosed idiopathic pulmonary fibrosis
title_full_unstemmed Prognostic implication of 1-year decline in diffusing capacity in newly diagnosed idiopathic pulmonary fibrosis
title_short Prognostic implication of 1-year decline in diffusing capacity in newly diagnosed idiopathic pulmonary fibrosis
title_sort prognostic implication of 1 year decline in diffusing capacity in newly diagnosed idiopathic pulmonary fibrosis
topic Idiopathic pulmonary fibrosis
Pulmonary diffusing capacity
Vital capacity
Disease progression
Respiratory function test
url https://doi.org/10.1038/s41598-024-59649-5
work_keys_str_mv AT hyeonsulee prognosticimplicationof1yeardeclineindiffusingcapacityinnewlydiagnosedidiopathicpulmonaryfibrosis
AT soyeonkim prognosticimplicationof1yeardeclineindiffusingcapacityinnewlydiagnosedidiopathicpulmonaryfibrosis
AT youngsikpark prognosticimplicationof1yeardeclineindiffusingcapacityinnewlydiagnosedidiopathicpulmonaryfibrosis
AT sunmichoi prognosticimplicationof1yeardeclineindiffusingcapacityinnewlydiagnosedidiopathicpulmonaryfibrosis
AT jonghyuklee prognosticimplicationof1yeardeclineindiffusingcapacityinnewlydiagnosedidiopathicpulmonaryfibrosis
AT jimyungpark prognosticimplicationof1yeardeclineindiffusingcapacityinnewlydiagnosedidiopathicpulmonaryfibrosis